Therapy for pustular psoriasis, rituximab-related psoriasis flare, methotrexate for children with localized scleroderma, methotrexate for skin lesions in dermatomyositis, treatment of non–infection-related cryoglobulinemic vasculitis, and hydroxychloroquine to prevent congenital heart block
Management of Patients with Pustular Psoriasis
Pustular psoriasis may be generalized or localized. Generalized pustular psoriasis (GPP) may be associated with severe, and at times life-threatening, disease, whereas localized pustular psoriasis (LPP) usually occurs on the palms or soles and is often disabling. No high-quality, evidence-based studies demonstrate effective treatment of GPP, but there is one placebo-controlled study utilizing cyclosporin for LPP.
These authors1 performed a thorough literature review and offer this guidance: For GPP, acitretin, cyclosporin, methotrexate, or infliximab should be the first-line therapy, with other anti-TNF agents, PUVA, and various topical agents as a second line. In pregnant women with GPP, avoid r…
Author
DisclosuresConsultant / Advisory board XOMA; Eli Lilly; Celgene
Equity Various trust accounts
Editorial boards JAMA Dermatology; UpToDate
Leadership positions in professional societies Association of Professors of Dermatology (President-Elect)
DisclosuresConsultant / Advisory board XOMA; Eli Lilly; Celgene
Equity Various trust accounts
Editorial boards JAMA Dermatology; UpToDate
Leadership positions in professional societies Association of Professors of Dermatology (President-Elect)